Weak Q1 earnings weigh on Camlin Fine Sciences

Camlin Fine Sciences lost 2.71% to Rs 87.90 at 13:43 IST on BSE after consolidated net profit fell 90.6% to Rs 1.31 crore on 14.3% growth in net sales to Rs 138.94 crore in Q1 June 2016 over Q1 June 2015.

The result was announced after market hours yesterday, 10 August 2016.

Meanwhile, the S&P BSE Sensex was up 2.09 points or 0.01% at 27,776.97.

On BSE, so far 58,000 shares were traded in the counter as against average daily volume of 31,561 shares in the past one quarter. The stock hit a high of Rs 89 and a low of Rs 84 so far during the day. The stock had hit a 52-week low of Rs 76.10 on 29 February 2016. The stock had hit a 52-week high of Rs 121.40 on 3 November 2015. The stock had underperformed the market over the past one month till 10 August 2016, sliding 6.13% compared with 2.39% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 9.7% as against Sensex's 7.77% rise.

The small-cap company has equity capital of Rs 10.32 crore. Face value per share is Rs 1.

Camlin Fine Sciences is a provider of high-quality shelf life extension solutions including antioxidants, aroma ingredients and performance chemicals.

Powered by Capital Market - Live News